Featured Research

from universities, journals, and other organizations

Old remedy shows promise as new chemo drug for bladder cancer

Date:
October 3, 2013
Source:
Loyola University Health System
Summary:
An old home remedy called ipecac syrup, once stocked in medicine cabinets in case of accidental poisoning, is showing promise as a new chemotherapy drug for bladder cancer.

An old home remedy called ipecac syrup, once stocked in medicine cabinets in case of accidental poisoning, is showing promise as a new chemotherapy drug for bladder cancer.

Years ago, ipecac syrup was used to induce vomiting in poisoning cases. Now a Loyola University Medical Center study has found that the active ingredient of ipecac syrup effectively inhibits the growth of bladder cancer cells, especially when combined with a standard chemotherapy drug.

The study by corresponding authors Kimberly Foreman, PhD, Gopal Gupta, MD, and colleagues is published online ahead of print in The Journal of Urology.

The active ingredient of ipecac syrup comes from the flowering plant Psychotria ipecacuanha. The drug no longer is recommended to induce vomiting. Studies have shown that vomiting after swallowing poison does not help, and sometimes can harm. Moreover, ipecac syrup can be abused by people with eating disorders.

Two small studies published in 1969 and 1970 found that the active ingredient of ipecac syrup, emetine dihydrochloride, helped in treating bladder cancer. Recent studies have found emetine also can kill leukemia cells.

In the new study, Loyola researchers exposed cell lines of normal and cancerous bladder cells to emetine alone and to emetine plus cisplatin. (Cisplatin is the standard chemotherapy drug for advanced bladder cancer.)

The study found, for the first time, that:

• Emetine alone inhibits the proliferation of bladder cancer cell lines.

• Emetine acts synergistically with cisplatin to inhibit bladder cancer proliferation better than either drug does alone.

• Emetine has little effect on normal cells.

Bladder cancer is the fourth most common cancer in men and the 9th most common cancer in women. But even with aggressive surgery and chemotherapy, the five-year survival rate for patients with advanced Stage 4 bladder cancer is only 4 to 20 percent.

"There is an urgent need to develop new drug combinations," Dr. Gupta said. "Our study demonstrates that combining emetine with cisplatin is potentially beneficial, and merits further study in clinical trials."


Story Source:

The above story is based on materials provided by Loyola University Health System. Note: Materials may be edited for content and length.


Journal Reference:

  1. Kimberly E. Foreman, John N. Jesse, Paul C. Kuo, Gopal N. Gupta. Emetine Dihydrochloride: A Novel Therapy for Bladder Cancer. The Journal of Urology, 2013; DOI: 10.1016/j.juro.2013.09.014

Cite This Page:

Loyola University Health System. "Old remedy shows promise as new chemo drug for bladder cancer." ScienceDaily. ScienceDaily, 3 October 2013. <www.sciencedaily.com/releases/2013/10/131003132110.htm>.
Loyola University Health System. (2013, October 3). Old remedy shows promise as new chemo drug for bladder cancer. ScienceDaily. Retrieved August 1, 2014 from www.sciencedaily.com/releases/2013/10/131003132110.htm
Loyola University Health System. "Old remedy shows promise as new chemo drug for bladder cancer." ScienceDaily. www.sciencedaily.com/releases/2013/10/131003132110.htm (accessed August 1, 2014).

Share This




More Health & Medicine News

Friday, August 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Texas Quintuplets Head Home

Texas Quintuplets Head Home

Reuters - US Online Video (Aug. 1, 2014) After four months in the hospital, the first quintuplets to be born at Baylor University Medical Center head home. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Ebola Patient Coming to U.S. for Treatment

Ebola Patient Coming to U.S. for Treatment

Reuters - US Online Video (Aug. 1, 2014) A U.S. aid worker infected with Ebola while working in West Africa will be treated in a high security ward at Emory University in Atlanta. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Ebola Vaccine Might Be Coming, But Where's It Been?

Ebola Vaccine Might Be Coming, But Where's It Been?

Newsy (Aug. 1, 2014) Health officials are working to fast-track a vaccine — the West-African Ebola outbreak has killed more than 700. But why didn't we already have one? Video provided by Newsy
Powered by NewsLook.com
Study Links Certain Birth Control Pills To Breast Cancer

Study Links Certain Birth Control Pills To Breast Cancer

Newsy (Aug. 1, 2014) Previous studies have made the link between birth control and breast cancer, but the latest makes the link to high-estrogen oral contraceptives. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins